Analystreport

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. They now have a $135.00 price target on the stock, down previ...

Jazz Pharmaceuticals plc - Ordinary Shares  (JAZZ) 
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: jazzpharma.com